Nexentis Technologies Inc. — fact timeline

Nexentis Technologies Inc. entered into securities purchase agreement with certain investors valued at approximately $2.9 million gross proceeds (effective 2026-06-22).

“On June 22, 2026, Nexentis Technologies Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain investors pursuant to which the Company agreed to sell and issue in a registered direct offering (the “Registered Direct Offering”) an aggregate of 410,998 of the Company’s shares of common stock (the “RD Shares”) at a purchase price of $7.056 per share.”

Nexentis Technologies Inc. issued 311,876 warrants to purchase up to 311,876 shares of warrant to same investors for aggregate gross proceeds of approximately $1.25 million.

“warranties, indemnification and other provisions customary for transactions of this nature. Aggregate gross proceeds to the Company in respect of the Offerings is approximately $1.25 million, before deducting offering expenses payable by the Company. The Offerings are expected to close on or about June 15, 2026, subject to satisfaction of customary closing”

Nexentis Technologies Inc. issued 311,876 of common stock to certain investors for aggregate gross proceeds of approximately $1.25 million.

“warranties, indemnification and other provisions customary for transactions of this nature. Aggregate gross proceeds to the Company in respect of the Offerings is approximately $1.25 million, before deducting offering expenses payable by the Company. The Offerings are expected to close on or about June 15, 2026, subject to satisfaction of customary closing”

Nexentis Technologies Inc. entered into Purchase Agreement with certain investors valued at approximately $1.25 million (effective 2026-06-12).

“On June 12, 2026, Nexentis Technologies Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain investors pursuant to which the Company agreed to sell and issue in a registered direct offering (the “Registered Direct Offering”) an aggregate of 311,876 of the Company’s shares of common stock (the “RD Shares”).”

Nexentis Technologies Inc. amended Amended and Restated Facility Agreement with L.I.A. Pure Capital Ltd. valued at Credit facility increased from EUR 6,000,000 to EUR 10,000,000; warrant terms amended to include pri (effective 2026-05-27).

“On April 30, 2026, Nexentis Technologies Inc. (the “Company”) held a special general meeting of stockholders (the “Special Meeting”) to approve, among others, an amendment to a facility agreement (the “Original Facility Agreement”) with L.I.A. Pure Capital Ltd. (the “Lender”) for financing of up to EUR 6,000,000 (the “Original Credit Facility”), EUR 2,000,000 of which may be used to finance one project in Germany, and the remaining EUR 4,000,000 for other projects subject to the Lender’s pre-approval.”

Nexentis Technologies Inc. shareholders approved Proposal No. 4 was to approve the authorization of an adjournment of the Special Meeting to a later date or dates, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the Reverse Stock Split Proposal, the Equity Issuance Proposal, or the Facility Amendment Propo at the 2026-04-30 meeting.

“Proposal #4. The Adjournment Proposal. Proposal No. 4 was to approve the authorization of an adjournment of the Special Meeting to a later date or dates, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the Reverse Stock Split Proposal, the Equity Issuance Proposal, or the Facility Amendment Proposal. The proposal was approved was approved as follows: For Against Abstain Broker Non-Votes 2,949,940 177,153 2,875 -”

Nexentis Technologies Inc. shareholders approved Proposal No. 3 was to approve, for Nasdaq Marketplace Rule 5635(d) purposes, the potential issuance of shares of Common Stock upon exercise of warrants that may be issued under an amendment to the Company's facility agreement with L.I.A. Pure Capital Ltd. (the "Facility Amendment Proposal"). at the 2026-04-30 meeting.

“Proposal #3. The Facility Amendment Proposal . Proposal No. 3 was to approve, for Nasdaq Marketplace Rule 5635(d) purposes, the potential issuance of shares of Common Stock upon exercise of warrants that may be issued under an amendment to the Company’s facility agreement with L.I.A. Pure Capital Ltd. (the “Facility Amendment Proposal”). The proposal was approved as follows: For Against Abstain Broker Non-Votes 1,789,433 98,561 466,614 775,360”

Nexentis Technologies Inc. shareholders approved Proposal No. 2 was to approve the issuance of securities in one or more non-public offerings where the maximum discount at which securities will be offered will be equivalent to a discount of 20% below the market price of the Company's Common Stock, as required by and in accordance with Nasdaq Marke at the 2026-04-30 meeting.

“Proposal #2. The Equity Issuance Proposal. Proposal No. 2 was to approve the issuance of securities in one or more non-public offerings where the maximum discount at which securities will be offered will be equivalent to a discount of 20% below the market price of the Company’s Common Stock, as required by and in accordance with Nasdaq Marketplace Rule 5635(d) (the “Equity Issuance Proposal”). The proposal was approved as follows: For Against Abstain Broker Non-Votes 2,230,497 112,345 11,766 775,360”

Nexentis Technologies Inc. shareholders approved Proposal No. 1 was to approve an amendment to the Company's Articles of Incorporation, as amended (the "Reverse Split Amendment"), implementing one or more reverse stock splits of the issued and outstanding shares of the Company's Common Stock (the "Reverse Stock Split") at a ratio of not less than at the 2026-04-30 meeting.

“Proposal #1. The Reverse Stock Split Proposal . Proposal No. 1 was to approve an amendment to the Company’s Articles of Incorporation, as amended (the “Reverse Split Amendment”), implementing one or more reverse stock splits of the issued and outstanding shares of the Company’s Common Stock (the “Reverse Stock Split”) at a ratio of not less than 1-for-2 and not more than 1-for-500 (the “Reverse Split Range”), and to grant the Company’s board of directors (the “Board”) the discretionary authority to determine the exact ratio of the Reverse Stock Split within the Reverse Split Range and by such number of increments, and to effect the Reverse Split Amendment at such times and dates, if at all, as to be determined by the Board in its sole discretion (the “Reverse Stock Split Proposal”). The proposal was approved as follows: For Against Abstain Broker Non-Votes 2,855,535 272,430 2,003 -”

Nexentis Technologies Inc.: The Company filed a Certificate of Amendment to effect a 1-for-7 reverse stock split of its common stock, effective April 7, 2026, reducing outstanding shares from 5,111,362 to approximately 730,309 (effective 2026-04-07).

“On April 3, 2026, the Company filed the Certificate of Amendment with the Secretary of State of the State of Nevada, to effect the Reverse Stock Split. The Certificate of Amendment will become effective on April 7, at 4:15 p.m. Eastern Daylight Time.”

Nexentis Technologies Inc. completed a disposition involving Voice Assist, Inc. for issuance of shares of common stock of Voice Assist representing 19.99% of Voice Assist on a fully-diluted basis (closed 2026-03-15).

“for the Shares consisted of the issuance at the Closing to the Company of that number of shares of common stock of Voice Assist, par value $0.001 per share, that represented 19.99% of Voice Assist on a fully-diluted basis, calculated as of immediately following the Closing. The foregoing description of the Agreement does not purport to be complete and is”

Nexentis Technologies Inc. issued 600,000 shares of common stock to consultants.

“On February 20, 2026, N2OFF, Inc. (the “Company”) issued 600,000 shares of common stock to consultants in consideration of various investor relations and business development services provided to the Company.”

Nexentis Technologies Inc.: Certificate of Amendment to Articles of Incorporation filed to change corporate name to Nexentis Technologies Inc (effective 2026-02-26).

“The Board of Directors of N2OFF, Inc., a Nevada corporation (the “Company”) approved on January 26, 2026 the change in the name of the Company to “Nexentis Technologies Inc.” (the “Name Change”) and the change in the trading symbol of the Company to “NXTS” on the Nasdaq Capital Market (the “Symbol Change”). To effectuate the Name Change, the Company filed a Certificate of Amendment to the Articles of Incorporation of the Company, as amended (the “Charter Amendment”) with the Secretary of State of the State of Nevada. The Name Change and the Symbol Change will take effect on the Nasdaq Capital Market on February 26, 2026.”

Nexentis Technologies Inc. entered into Services Agreement with Voice Assist, Inc. valued at Company provides advisory services to Voice Assist in exchange for deferred cash consideration up to (effective 2026-01-13).

“The Company also entered into a Services Agreement with Voice Assist (the “Services Agreement”), pursuant to which the Company will provide non-exclusive general advisory, support, collaboration and related services to Voice Assist from time to time.”

Nexentis Technologies Inc. entered into Securities Exchange Agreement with Voice Assist, Inc. valued at transfer of approximately 98% of Save Foods ordinary shares to Voice Assist in exchange for 19.99% o (effective 2026-01-13).

“On January 13, 2026, N2OFF, Inc., a Nevada corporation (the “Company”), entered into a Securities Exchange Agreement (the “Agreement”) with Voice Assist, Inc., a public company incorporated under the laws of the State of Nevada (“Voice Assist”), and, for certain limited purposes set forth therein, Save Foods Ltd., a private company incorporated under the laws of the State of Israel and a majority-owned subsidiary of the Company (“Save Foods”, and together with the Company and Voice Assist, the “Parties”).”

Nexentis Technologies Inc. issued 60,000 shares of common stock to consultants for various investor relations services.

“On December 15, 2025, N2OFF, Inc. (the “Company”) issued 60,000 shares of common stock pursuant to new consulting agreements to consultants in consideration of various investor relations services provided to the Company.”

Nexentis Technologies Inc. completed an acquisition involving SciSparc Ltd, Dr. Alon Silberman, and Prof. Ciro Leonardo Pierri (collectively, the Sellers) (closed 2025-10-20).

“On October 20, 2025, upon the satisfaction of the remaining closing conditions in the Agreement, the Acquisition closed (the "Closing").”

Nexentis Technologies Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“October 6, 2025, N2OFF, Inc. (the “Company”) received a written notification (the “Notification”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has regained compliance with the Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share for the Company’s common stock. As previously reported, on March 28, 2025, the Company received notice from Nasdaq that it was not in compliance with the minimum bid price requirement. The Notification states that for 10 consecutive business days from September 22, 2025 through October 3, 2025, the closing bid”

Nexentis Technologies Inc.: Certificate of Amendment to Amended and Restated Articles of Incorporation filed to effect a 1-for-35 reverse stock split (effective 2025-09-03).

“On September 3, 2025, the Company filed a Certificate of Amendment to its Amended and Restated Articles of Incorporation (the “Certificate of Amendment” and the “Articles of Incorporation”) with the Secretary of State of the State of Nevada, to effect the Reverse Stock Split as a corporate action under its Articles of Incorporation.”

Nexentis Technologies Inc. incurred loan of $1,500,000 with YA II PN, Ltd..

“On August 12, 2025, pursuant to the terms and conditions of the Purchase Agreement, as amended, the Investor paid to the Company the first portion of the Advance in the amount of $1,500,000 and the Company issued a promissory note in the principal amount of $1,500,000 to the Investor (the “Note”).”

Nexentis Technologies Inc. incurred convertible notes of $3,000,000 with YA II PN, Ltd. at 8% per annum maturing 12 months from issuance.

“a Purchase Agreement (the “Agreement”) with YA II PN, Ltd. (the “Investor”) pursuant to which the Investor committed to advance the Company the aggregate principal amount of $3,000,000, of which (i) up to $1,500,000 will be made available within 60 days following the date a new registration statement has been filed by the Company with the Securities and Exchange”

Nexentis Technologies Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5810(c)(3)(H)).

“March 28, 2025, N2OFF, Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days the closing bid price for the Company’s common stock, par value $0.0001 per share (the “Common Stock”), was below $1.00 per share, which is the minimum closing bid price required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Notice”). This Notice has no immediate effect on the listing of the Company’s Common Stock which will con”

Nexentis Technologies Inc.: Reduced quorum requirement from majority to 33.33% of voting power (effective 2024-11-11).

“On and effective as of November 11, 2024, the board of directors of N2OFF, Inc. (the “Company”) approved and adopted amended and restated bylaws of the Company (the “Amended and Restated Bylaws”), which changed the quorum requirement set forth in Section 5 of Article I thereof, from “ A majority of the shares entitled to vote, present in person or represented by proxy, shall constitute a quorum at any meeting of stockholders ...” to now read, “the holders of not less than 33.33% of the voting power of all of the shares of the stock entitled to vote at the meeting, present in person or by proxy, shall constitute a quorum...”.”

Nexentis Technologies Inc. incurred loan of $1,500,000 promissory note with YA II PN, Ltd. at 8% per annum maturing April 4, 2025.

“On April 4, 2024, N2OFF, Inc., a Nevada corporation (the “Company”), sold a $1,500,000 promissory note (the “Note”) to YA II PN, Ltd. (the “Investor”) in exchange for proceeds of $1,455,000, reflecting an original issue discount of 3% to face value.”

Nexentis Technologies Inc. entered into Note with YA II PN, Ltd. valued at $1,500,000 promissory note (effective 2024-04-04).

“On April 4, 2024, N2OFF, Inc., a Nevada corporation (the “Company”), sold a $1,500,000 promissory note (the “Note”) to YA II PN, Ltd. (the “Investor”) in exchange for proceeds of $1,455,000, reflecting an original issue discount of 3% to face value .”

Nexentis Technologies Inc.: Company amended Articles of Incorporation to change name from Save Foods, Inc. to N2OFF, Inc (effective 2024-03-19).

“On March 15, 2024, Save Foods, Inc. (now known as N2OFF, Inc.), a Nevada corporation (the “Company”), filed an amendment to its Articles of Incorporation with the Secretary of State of the State of Nevada (the “Amendment”) to change the name of the Company to “N2OFF, Inc.” (the “Name Change”). Pursuant to the Amendment, the Name Change became effective on March 19, 2024, at 12:01 a.m. Pacific Time.”

Nexentis Technologies Inc. shareholders approved Proposal No. 2 was to approve the issuance of 20% or more of the Company’s issued and outstanding shares of Common Stock in a non-public offering pursuant to the terms of the Standby Equity Purchase Agreement, dated December 22, 2023, by and between the Company and YA II PN, Ltd., so that such issua at the 2024-02-08 meeting.

“Proposal #2. T he Nasdaq 20% Share Issuance Proposal . Proposal No. 2 was to approve the issuance of 20% or more of the Company’s issued and outstanding shares of Common Stock in a non-public offering pursuant to the terms of the Standby Equity Purchase Agreement, dated December 22, 2023, by and between the Company and YA II PN, Ltd., so that such issuances are made in accordance with Nasdaq Listing Rule 5635 of the Nasdaq Capital Market. This proposal was approved as follows: For Against Abstain Broker Non-Votes 1,331,232 30,467 112,139 240,687”

Nexentis Technologies Inc. shareholders approved Proposal No. 1 was to approve an amendment to the Articles of Incorporation of the Company implementing the change of the name of the Company from "Save Foods, Inc." to "N2OFF, Inc." at the 2024-02-08 meeting.

“Proposal #1 . The Name Change Proposal. Proposal No. 1 was t o approve an amendment to the Articles of Incorporation of the Company implementing the change of the name of the Company from “Save Foods, Inc.” to “N2OFF, Inc.” This proposal was approved as follows: For Against Abstain 1,598,782 102,193 13,550”

Asaf Itzhaik was appointed as Class II Director at Nexentis Technologies Inc..

“On December 20, 2023, the board of directors of the Company (the “Board”) appointed Asaf Itzhaik to the Board, effective immediately,”

Dr. Roy Borochov resigned as Director at Nexentis Technologies Inc..

“to replace Dr. Roy Borochov who resigned from the Board on December 15, 2023.”

Dr. Roy Borochov resigned as member of the board of directors at Nexentis Technologies Inc..

“On December 15, 2023, Dr. Roy Borochov notified Save Foods, Inc. (the “Company”) of his resignation as a member of the board of directors (the “Board”), effective immediately.”

Liat Sidi was appointed as Class II director at Nexentis Technologies Inc..

“appointed Liat Sidi to the Board, effective immediately, to serve as a Class II director”

Nexentis Technologies Inc.: Reincorporated from Delaware to Nevada, with the certificate/ articles of incorporation now governed by Nevada law; effective November 6, 2023 (effective 2023-11-06).

“Effective as of November 6, 2023 (the “Effective Day”), Parent merged with and into the Company, with the Company being the surviving corporation and successor in interest to Parent. The purpose of the Reincorporation Merger was to re-domicile Parent from Delaware to Nevada.”

Nexentis Technologies Inc. entered into Agreement and Plan of Merger with Save Foods, Inc., a newly formed Nevada corporation and its wholly owned subsidiary (the "Surviving Corporation" or the "Company") (effective 2023-11-06).

“On November 6, 2023, Save Foods, Inc., a Delaware corporation ("Parent") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Save Foods, Inc., a newly formed Nevada corporation and its wholly owned subsidiary (the "Surviving Corporation" or the "Company"), pursuant to which, on the same date, Parent merged with and into the Surviving Corporation (the "Reincorporation Merger").”

Nexentis Technologies Inc. incurred loan of $700,000 with YA II PN, Ltd. at 8% per annum maturing one year.

“On October 31, 2023, Save Foods, Inc., a Delaware corporation (the “Company”) issued a one-year promissory note in the principal amount of $700,000 (the “Note”) to YA II PN, Ltd. (the “Investor”)”

Nexentis Technologies Inc.: Amendment to Certificate of Incorporation to effect a 1-for-7 reverse stock split to regain Nasdaq compliance (effective 2023-10-05).

“On October 4, 2023, the Company filed the Certificate of Amendment with the Secretary of State of the State of Delaware, to effect the Reverse Stock Split. The Certificate of Amendment became effective on October 5, 2023, at 9 a.m. Eastern Daylight time (the “Effective Time”).”

Nexentis Technologies Inc. shareholders approved Non-binding advisory vote to approve grant of shares under 2022 Plan to each board member (excluding Dr. Borochov) at the 2023-10-02 meeting.

“Proposal #7. The Advisory Vote on Grant of Shares Proposal. Proposal No. 7 was to vote on a non-binding resolution to approve a grant of shares under the 2022 Plan, as compensation to each member of the Board (excluding Dr. Borochov). This proposal was subject to the approval of Proposal #2, the 2022 Plan Amendment (which became effective immediately after the adjournment of the Annual Meeting). This proposal was approved as follows: For Against Abstain Broker Non-Votes 5,410,852 166,435 2,474 983,855”

Nexentis Technologies Inc. shareholders approved Ratify appointment of Somekh Chaikin (KPMG International) as independent auditors for fiscal year 2023 at the 2023-10-02 meeting.

“Proposal #6. The Auditor Appointment Proposal . Proposal No. 6 was to ratify the appointment of Somekh Chaikin, a member firm of KPMG International, as the Company’s independent auditors for the fiscal year ended December 31, 2023. This proposal was approved as follows: For Against Abstain 6,325,286 197,821 40,509”

Nexentis Technologies Inc. shareholders approved Approve reincorporation from Delaware to Nevada by parent-subsidiary merger at the 2023-10-02 meeting.

“Proposal #5. The Reincorporation Proposal . Proposal No. 5 was to approve the reincorporation of the Company from the State of Delaware to the State of Nevada by a parent-subsidiary merger. This proposal was approved as follows: For Against Abstain Broker Non-Votes 5,573,429 6,117 215 983,855”

Nexentis Technologies Inc. shareholders approved Approve issuance of more than 20% of issued and outstanding Common Stock in non-public offering under Standby Equity Purchase Agreement at the 2023-10-02 meeting.

“Proposal #4. The Nasdaq 20% Share Issuance Proposal . Proposal No. 4 was to approve the issuance of more than 20% of our issued and outstanding Common Stock in a non-public offering pursuant to the terms of the Standby Equity Purchase Agreement, dated July 23, 2023, by and between the Company and YA II PN, Ltd., so that such issuances are made in accordance with Nasdaq Listing Rule 5635. The proposal was approved was approved as follows: For Against Abstain Broker Non-Votes 5,374,299 82,255 123,207 983,855”

Nexentis Technologies Inc. shareholders approved Approve amendment to certificate of incorporation to effect reverse stock split of Common Stock by ratio of 1-for-7 to 1-for-10 at the 2023-10-02 meeting.

“Proposal #3. The Reverse Stock Split Proposal . Proposal No. 3 was to approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Common Stock, by a ratio of no less than 1-for-7 and no more than 1-for-10, with the exact ratio to be determined by the Board in its sole discretion. The proposal was approved as follows: For Against Abstain 5,377,519 77,073 125,169”

Nexentis Technologies Inc. shareholders approved Approve amendment to the Save Foods, Inc. 2022 Share Incentive Plan to increase authorized shares by 6,500,000 at the 2023-10-02 meeting.

“Proposal #2. The 2022 Plan Amendment. Proposal No. 2 was to approve an amendment to the Save Foods, Inc. 2022 Share Incentive Plan (the “2022 Plan”), to increase the number of shares of Common Stock authorized for issuance under the 2022 Plan by an additional 6,500,000 shares of our Common Stock, which amendment (the “2022 Plan Amendment”) was adopted by the Board on July 31, 2023. This proposal was approved as follows, resulting in the 2022 Plan Amendment becoming effective immediately: For Against Abstain Broker Non-Votes 5,413,722 163,788 2,251 983,855”

Nexentis Technologies Inc. shareholders approved Reelect Amitay Weiss and Dr. Roy Borochov, two Class II directors at the 2023-10-02 meeting.

“Proposal #1. The Director Election Proposal . Proposal No. 1 was to reelect Amitay Weiss and Dr. Roy Borochov, two Class II directors nominated for election, each to serve a three-year term on the Company’s board of directors (the “Board”). This proposal was approved as follows: Director For Against Abstain (a) Amitay Weiss 5,489,988 88,179 1,594 (b) Dr. Roy Borochov 5,519,612 59,555 594”

Nexentis Technologies Inc. amended Stock Exchange Agreement (as amended by First Amendment and Second Amendment) with Yaaran Investments Ltd. valued at Issuance of 1,561,051 Save Foods Exchange Shares and NewCo Exchange Shares representing 60% of NewCo (effective 2023-08-13).

“On August 13, 2023, the Parties entered into a second amendment to the Agreement whereby the Parties agreed that upon the formation of NewCo, the NewCo Exchange Shares will be issued to the Company, instead of the Company’s subsidiary, Save Foods Ltd.”

Nexentis Technologies Inc. entered into Purchase Agreement with YA II PN, Ltd. valued at $3.5 million (effective 2023-07-23).

“On July 23, 2023, Save Foods, Inc., a Delaware corporation (the “Company”), entered into a Standby Equity Purchase Agreement (the “Purchase Agreement”), with YA II PN, Ltd. (the “Investor”), pursuant to which the Investor has agreed to purchase up to $3.5 million shares of the Company’s common stock”

Lital Barda was appointed as Chief Financial Officer at Nexentis Technologies Inc..

“Effective July 16, 2023, Mr. David Palach’s term as Interim Chief Financial Officer of Save Foods, Inc. (the “Company”) concluded following Ms. Lital Barda’s return from maternity leave.”

David Palach departed as Interim Chief Financial Officer at Nexentis Technologies Inc..

“Effective July 16, 2023, Mr. David Palach’s term as Interim Chief Financial Officer of Save Foods, Inc. (the “Company”) concluded following Ms. Lital Barda’s return from maternity leave.”

Nexentis Technologies Inc. entered into Agreement with Yaaran Investments Ltd. and NewCo (effective 2023-07-11).

“On July 11, 2023, Save Foods, Inc. (the “Company” or “Save Foods”), entered into a stock exchange agreement (the “Agreement”), by and among the Company, Save Foods Ltd., an Israeli company, Yaaran Investments Ltd., an Israeli company (“Yaaran”), and NewCo, a yet-to-be formed Israeli company (“NewCo”, and together, the “Parties”), pursuant to which the Company agreed to issue to Yaaran 19.99% of its issued and outstanding capital stock as of immediately prior to the Closing (as defined in the Agreement), and in consideration thereof Save Foods Ltd., the majority-owned subsidiary of the Company, shall be issued such number of shares representing 60% of NewCo’s share capital on a fully diluted pre-Closing basis.”

Nexentis Technologies Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“April 25, 2023, Save Foods, Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock, par value $0.0001 per share (the “Common Stock”), was below $1.00 per share, which is the minimum closing bid price required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Notice”). This Notice is a notice of deficiency, not delisting, and has no immediate effect on the”

Nexentis Technologies Inc. entered into Debenture with Plantify Foods, Inc. valued at C$1,500,000.

“In connection with, and contingent upon, the execution of the Agreement, Save Foods and Plantify executed a debenture (the “Debenture”), whereby Save Foods agreed to lend C$1,500,000 to Plantify (the “Principal”), which Principal will accrue interest at a rate of 8% annually and will be repayable by Plantify over approximately 18 months.”